Theme: Emerging Technologies and Scientific Advancements in Pharmacovigilance and Drug Safety

Euro Pharmacovigilance 2019

Renowned Speakers

Euro Pharmacovigilance 2019

We warmly welcome all the participants to attend our event Euro Pharmacovigilance Meet 2019 entitled “European Conference on Pharmacovigilance & Drug Safety ” scheduled during November  18-19, 2019 in Prague, Czech Republic which includes a large range of prompt Keynote presentations, Poster presentations, Oral presentation, Exhibitions, Symposiums & Workshops. It's a right  platform for researchers, scientists and delegates to share their expertise, poster collaborations across business and domain, and valuate rising technologies across the globe.

Conference series LLC Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000more scientific societies and Publishes 700+ Open access Journals which contains over 70000 eminent personalities as editorial board members as reputed scientists and 1200+ Symposiums & Workshops.

Why to attend:

A great opportunity to network with your peers from academia and industry

With members from around the world focused on learning about pharmacovigilance and its advances; this is your best opportunity to reach the largest assemblage of participants from the Euro pharmacovigilance community.

Target Audience:

Researchers & Innovators

  •  Experts Looking for Collaborative Work
  •  Product Developers
  •  Solution Providers
  • Pharmacovigilance Students, Scientists
  • Software Developing Companies
  • Funding Agencies & Fund Raisers
  • Management Bodies
  • Decision Makers

Abstract Submissions 

Euro Pharmacovigilance 2019 invites the submission of abstracts of original work. Abstracts must be submitted on the understanding that they have not been presented else where (except in the form of a thesis) and are not currently under consideration by another conference. The submitting speaker should ensure that the abstract publication has been approved by all other co-authors.

Modes of Presentation

  1. Oral presentation
  2. Poster presentation


All abstracts must be written exclusively in English (including the title, abstract text, author names and affiliations).


Please provide the following:

Presenting author’s contact details including full mailing address, office phone number, email address and fax numberName(s) of presenting author and co-authors: first name(s) or initials of first name(s), family name (e.g. Jason Wong or J. Wong)

Affiliation details of all authors: Department, institution/hospital, city, state (if relevant), country.



 Track 1: Pharmacovigilance and Drug Safety:

Pharmacovigilance and Drug Safety will having the rapid development of new drug and innovative therapeutics, new pharmacovigilance procedures and methods have to be implemented for assurance of drug safety and the quality of life of patients.

  • Post marketing Clinical Trials
  • Adverse event reporting
  • Risk management
  • Pharmacoenvironmentology

Track 2: Pharmacovigilance and Risk management:

A set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks relating to medicinal products, including the assessment of the effectiveness of those interventions. The need for a risk management

  • New marketing authorisation involving
  • Significant changes to Marketing Authorisation
  • On request from a Competent Authority
  • On company initiative e.g. safety issue with a marketed medicines
  • Update to previous EU-RMP

Track 3 : Adverse Event Reporting:

An adverse drug reaction (ADR) is an injury caused by taking medication. Its may occur following a single dose or prolonged administration of a drug or result from the combination of two or more drugs. In the US, 3 to 7% of all hospitalizations are due to adverse drug reactions. Occurrence of death due to ADRs is unknown suggested rates of 0.5 to 0.9% may be falsely high because many of the patients included had serious and difficult disorders.

  • Life-threatening
  • Congenital abnormality
  • Hospitalization (initial or prolonged)
  • cause and severity

Track 4 : Clinical Research and Statistica:

In Clinical Research, Statistics plays a prominent role in regulatory submissions. Statistical analysis of pharmacovigilance can be achieved by several guidelines mainly ICH guidelines. Adverse Drug Reactions reports can also be considered for the regulatory submission.

  • SAS  seen in Clinical Research and Pharmaceutical Industry
  • ICH guidelines for clinical research and its statistics
  • Case reports used in pregnancy and lactation

Track 5 : Drug Discovery:

More recently, chemical libraries of synthetic small molecules, natural products or extracts were separated in intact cells or whole organisms to identify substances that had a desirable healing effect in a process known as classical pharmacology. Discovering drugs that may be a commercial success or a public health success

  • Cardiovascular Drug Discovery
  • Novel Therapeutics in Drug Designing
  • Drug Designing and Molecular Modelling

Track 6 : Pharma Practices:

Pharmaceutical Care is a patient-centred .Pharmacy practice is the discipline of pharmacy which involves developing the professional roles of pharmacists. The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medicines to be administered  to patients.

  • Industrial pharmaceutics
  • Drug Label

Track 7: Regulatory affairs:

Regulatory affairs is a profession developed from the desire of governments to protect public health by controlling the safety and efficacy of products in areas including pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicines, and by the companies responsible for the discovery, testing, manufacture and marketing of these products wanting to ensure that they supply products that are safe and make a worthwhile contribution to public health and welfare.

  • Regulatory Guidelines
  • MHRA
  • Regulations in Pharmacovigilance

 Track 8: Business Opportunity for Pharmacovigilance:

Regulatory Affairs department is constantly evolving and growing and is the one which is least impacted during the Acquisition and Merger, and also during recession. The global Pharmacovigilance market and Business opportunity was valued at USD 2,408.0 million in 2013 and is expected to grow at a CAGR of 12.6% during the forecast period. Phase III clinical trials market was the second largest and was valued at over USD 750.0 million in 2013.

  • Career Growth in PV Consulting
  • Pharmacovigilance software Development Companies
  • Business Opportunities for PV Software Developing Companies

Track 9 : Pharmacovigilance significance scope:

Concept of Pharmacovigilance and its Significance enhances the impact of pharmacovigilance on patient welfare and public health and to know what is pharmacovigilance. This will give a brief discussion on Pharmacovigilance role in healthcare system. The Role of Pharma industries in the improvement of pharmacovigilance system is very crucial to maintain the safety data, Detection and Evaluation of drug safety signals through manual and medical devices reporting. Pharmacovigilance scope also deals with

  • Eco-pharmacovigilance (EPV),
  • Pharmacoenvironmentology
  • Pharmacovigilance in Herbal Medicine Significance of pharmacovigilance

Track 10 : Bio-Pharmaceutics:

Bio pharmaceutics is one of the main branch in Pharmaceutical Sciences which relates the physicochemical properties of the drugs - dosage form, pharmacology, toxicology / clinical response observed after its administration. Bio pharmaceutics uses the exact formulation to obtain the drug with new dosage form as related to the onset, duration, and intensity of drug action, including constituents and mode of manufacture.

  • Bioavailability and bioequivalence
  • Drug disposition
  • Invivo-Invitro correlation
  • Pharmacodynamics
  • Drug Interaction
  • Bio analytical method
  • Clinical Pharmacology
  • Clinical toxicology
  • Biomarkers
  • Recent Biomedical Innovation

Track 11: Drug Tolerance:

Drug tolerance should not be confuse with drug tolerability, which refers to the degree to which obvious adverse effects of a medicine can tolerated by a patient. A common cause of pharmacodynamics tolerance is high concentrations of a substance constantly binding with the receptor Tachyphylaxis is a subcategory of drug tolerance referring to cases of sudden, short-term onset of tolerance following the organization of a drug ..

  • Drug tolerance mechanism
  • Behaviour tolerance
  • Pharmacodynamics tolerance
  • Tachyphylaxis
  • Cross tolerance

Track 12 : Entrepreneurs Investment Meet:

Green Energy- 2019 facilitates a unique platform for transform the  potential ideas into great business. The present meeting/ creates a global platform to connect global Entrepreneurs, Proposers and the Investors in the field of Renewable Energy and its allied sciences. This investment meet facilitates the most optimized and practical business for engaging people in to constructive discussions, evaluation and execution of promising business.

  • Initial Investment
  • Capita Requirement
  • Business Financing
  • Current Trends




Market Analysis

Pharmacovigilance 2019 welcomes attendees, presenters, and exhibitors from all over the world to Valencia, Spain. We are delighted to invite you all to attend and register for the “European conference on Pharmacovigilance & drug safety ” which is going to be held during November 28-29, 2019 Prague Czech Republic. The Organizing Committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Pharmacovigilance 2019, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Pharmacovigilance 2019 Organizing Committee will look forward to meet you at Prague, Republic.

This market is experiencing a significant boost owing to patent expiration of branded drugs and increasing number of new drug developments. This has attracted several local and international pharmacovigilance service providers. Presence of competitive milieu has led to improved clinical data management, pharmacovigilance and streamlined R&D process.


Concept of Pharmacovigilance and its Significance enhances the impact of pharmacovigilance on patient welfare and public health and to understand what's pharmacovigilance. This track offers a quick discussion on Pharmacovigilance role in healthcare system. Pharmacovigilance legislation offers associate degree outlook on the principles and laws to follow in Pharmacovigilance practice. The Role of company industries within the improvement of pharmacovigilance system is extremely crucial to keep up the security information, Detection and analysis of drug safety signals through manual and medical devices coverage. Pharmacovigilance scope additionally deals as Ecopharmacovigilance (EPV), pharmacoenvironmentology and pharmacovigilance in seasoning medicines.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date 2019-11-18
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed
Poster Opportunity Closed Click Here to View